Albany, NY -- (SBWIRE) -- 02/21/2018 -- The global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market report, offers in-depth insights, revenue details, and other vital information regarding the global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2026. The report also offers insightful and detailed information regarding the various key players operating in the global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market, and their financials, apart from strategies, acquisitions & mergers, and market footprint. The global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market is segmented on the basis of security type, component, application area, and region.

Product innovation has become a vital concept for companies looking to explore new technology horizons. We witness daily how organizations use it to drive new methods of engagement and digital operations and execution.

This report focuses on the top players in global market, like
Qiagen NV
GE Healthcare
Agilent Technologies
F Hoffman La Roche
Foundation Medicine
Thermo Fisher Scientific Inc.
Leica Biosystems Nussloch GmBH
Pfizer

Request for sample copy of report : https://www.marketresearchreports.biz/sample/sample/1486733

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, the product can be split into
PCR
In-situ Hybridization
Immunohistochemistry
Sequencing
Others

Market segment by Application, Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) can be split into
Oncology
Neurological Disorders
Cardiovascular Disease
Immunological Disorders
Others

Table of Contents

Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size, Status and Forecast 2025
1 Industry Overview of Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx)
1.1 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Overview
1.1.1 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product Scope
1.1.2 Market Status and Outlook
1.2 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Analysis by Regions (2013-2018)
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market by Type
1.3.1 PCR
1.3.2 In-situ Hybridization
1.3.3 Immunohistochemistry
1.3.4 Sequencing
1.3.5 Others
1.4 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market by End Users/Application
1.4.1 Oncology
1.4.2 Neurological Disorders
1.4.3 Cardiovascular Disease
1.4.4 Immunological Disorders
1.4.5 Others

Request for TOC of this report : https://www.marketresearchreports.biz/reports/1486733/global-pharmacogenomics-technology-theranostics-companion-market-research-reports/toc

2 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Competition Analysis by Players
2.1 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Qiagen NV
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (Million USD) (2013-2018)
3.1.5 Recent Developments
3.2 GE Healthcare
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (Million USD) (2013-2018)
3.2.5 Recent Developments
3.3 Agilent Technologies
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (Million USD) (2013-2018)
3.3.5 Recent Developments
3.4 F Hoffman La Roche
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (Million USD) (2013-2018)
3.4.5 Recent Developments
3.5 Foundation Medicine
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (Million USD) (2013-2018)
3.5.5 Recent Developments
3.6 Thermo Fisher Scientific Inc.
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (Million USD) (2013-2018)
3.6.5 Recent Developments
3.7 Leica Biosystems Nussloch GmBH
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (Million USD) (2013-2018)
3.7.5 Recent Developments
3.8 Pfizer
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (Million USD) (2013-2018)
3.8.5 Recent Developments

4 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type and Application (2013-2018)
4.1 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2013-2018)
4.2 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2013-2018)
4.3 Potential Application of Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) in Future
4.4 Top Consumer/End Users of Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx)

5 United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Development Status and Outlook
5.1 United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2013-2018)
5.2 United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Market Share by Players (2013-2018)
5.3 United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2013-2018)

6 EU Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Development Status and Outlook
6.1 EU Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2013-2018)
6.2 EU Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Market Share by Players (2013-2018)
6.3 EU Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2013-2018)

7 Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Development Status and Outlook
7.1 Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2013-2018)
7.2 Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Market Share by Players (2013-2018)
7.3 Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2013-2018)

Get more details : https://www.marketresearchreports.biz/reports/1486733/global-pharmacogenomics-technology-theranostics-companion-market-research-reports

8 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Development Status and Outlook
8.1 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2013-2018)
8.2 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Market Share by Players (2013-2018)
8.3 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2013-2018)

9 India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Development Status and Outlook
9.1 India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2013-2018)
9.2 India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Market Share by Players (2013-2018)
9.3 India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2013-2018)